Literature DB >> 19879056

Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.

Jamie R Doyle1, Bryan K Yamamoto.   

Abstract

Chronic stress precipitates drug seeking behavior and alters the effects of drugs of abuse. Although it is known that chronic stress potentiates acute neurochemical and hyperthermic responses to the drug of abuse methamphetamine, no studies have investigated if and how chronic stress alters other physiological responses to methamphetamine. Therefore the objective of these studies was to determine if 10 days of chronic unpredictable stress modulates corticosterone (CORT) responses to methamphetamine and furthermore how chronic stress may modulate methamphetamine-induced increases in hyperthermia and CORT. As chronic stress potentiates hyperthermic responses to serotonin 2 (5-HT2) stimulation and 5-HT2 receptors are important in mediating both hyperthermic and CORT responses, we also investigated if 5-HT2 antagonism would block hyperthermia and CORT secretion by the serial exposure to stress and methamphetamine (stress/methamphetamine). The results of these studies illustrate that stress potentiates methamphetamine-induced increases in body temperature and CORT secretion and that these increases are blocked by the 5-HT2 antagonist ketanserin. Furthermore, the combination of stress and methamphetamine depletes 5-HT content in the hippocampus 7 days after methamphetamine administration which is blocked by the 5-HT2 antagonist ketanserin. Overall, these results indicate a pharmacological mechanism for the depletion of hippocampal 5-HT by the serial exposure to stress and methamphetamine and further illustrate the deleterious interactions between chronic stress and methamphetamine use. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879056      PMCID: PMC3951178          DOI: 10.1016/j.psyneuen.2009.10.001

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  16 in total

Review 1.  Interaction between glucocorticoid hormones, stress and psychostimulant drugs.

Authors:  Michela Marinelli; Pier Vincenzo Piazza
Journal:  Eur J Neurosci       Date:  2002-08       Impact factor: 3.386

2.  Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.

Authors:  M Johnson; D M Stone; L G Bush; G R Hanson; J W Gibb
Journal:  Eur J Pharmacol       Date:  1989-02-28       Impact factor: 4.432

3.  Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.

Authors:  Yoshimoto Sekine; Yasuomi Ouchi; Nori Takei; Etsuji Yoshikawa; Kazuhiko Nakamura; Masami Futatsubashi; Hiroyuki Okada; Yoshio Minabe; Katsuaki Suzuki; Yasuhide Iwata; Kenji J Tsuchiya; Hideo Tsukada; Masaomi Iyo; Norio Mori
Journal:  Arch Gen Psychiatry       Date:  2006-01

4.  Structural abnormalities in the brains of human subjects who use methamphetamine.

Authors:  Paul M Thompson; Kiralee M Hayashi; Sara L Simon; Jennifer A Geaga; Michael S Hong; Yihong Sui; Jessica Y Lee; Arthur W Toga; Walter Ling; Edythe D London
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

5.  Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats.

Authors:  Leslie Matuszewich; Bryan K Yamamoto
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

6.  Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function.

Authors:  M T Lin; H J Tsay; W H Su; F Y Chueh
Journal:  Am J Physiol       Date:  1998-05

7.  Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

Authors:  J F Nash; H Y Meltzer; G A Gudelsky
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

8.  Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.

Authors:  Despina A Tata; Jamie Raudensky; Bryan K Yamamoto
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

9.  Further studies of the role of hyperthermia in methamphetamine neurotoxicity.

Authors:  J F Bowyer; D L Davies; L Schmued; H W Broening; G D Newport; W Slikker; R R Holson
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

10.  Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.

Authors:  R Kuczenski; D S Segal; A K Cho; W Melega
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

View more
  9 in total

1.  Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration.

Authors:  Lisa M McFadden; Amanda J Hoonakker; Paula L Vieira-Brock; Kristen A Stout; Nicole M Sawada; Jonathan D Ellis; Scott C Allen; Elliot T Walters; Shannon M Nielsen; James W Gibb; Mario E Alburges; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

2.  Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.

Authors:  Bethann N Johnson; Bryan K Yamamoto
Journal:  J Pharmacol Exp Ther       Date:  2010-07-15       Impact factor: 4.030

3.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

4.  Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.

Authors:  Thibault Renoir; Terence Y C Pang; Christina Mo; Grace Chan; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

5.  The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2013-07-27       Impact factor: 2.562

6.  Protracted effects of chronic stress on serotonin-dependent thermoregulation.

Authors:  Reka Natarajan; Nicole A Northrop; Bryan K Yamamoto
Journal:  Stress       Date:  2015-09-28       Impact factor: 3.493

7.  Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine.

Authors:  Nicole A Northrop; Bryan K Yamamoto
Journal:  Neuropharmacology       Date:  2013-05-02       Impact factor: 5.250

Review 8.  Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Authors:  Rae R Matsumoto; Michael J Seminerio; Ryan C Turner; Matthew J Robson; Linda Nguyen; Diane B Miller; James P O'Callaghan
Journal:  Pharmacol Ther       Date:  2014-05-14       Impact factor: 12.310

Review 9.  Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications.

Authors:  Yufeng Wei; Rameen Shah
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.